Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference45 articles.
1. Comparative effectiveness of pemetrexed-platinum doublet chemotherapy with or without bevacizumab as first-line therapy for treatment-naive patients with advanced nonsquamous non-small-cell lung cancer in China;Li;Clin Ther.,2019
2. Comparative effectiveness study of single high-dose cisplatin with fractionated doses cisplatin in first-line therapy for treatment-naive Chinese patients with advanced non-small-cell lung cancer;Li;Curr Probl Cancer.,2019
3. Current and prospective protein biomarkers of lung cancer;Zamay;Cancers.,2017
4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin.,2018
5. Epidemiology of lung cancer in China;Cao;Thorac Cancer.,2019
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. High-precision bladder cancer diagnosis method: 2D Raman spectrum figures based on maintenance technology combined with automatic weighted feature fusion network;Analytica Chimica Acta;2023-11
2. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update;Tumor Biology;2023-10-28
3. Biomarkers of lung cancer for screening and in never-smokers—a narrative review;Translational Lung Cancer Research;2023-10
4. Machine learning prediction models for different stages of non-small cell lung cancer based on tongue and tumor marker: a pilot study;BMC Medical Informatics and Decision Making;2023-09-29
5. Status quo of Extracellular Vesicle isolation and detection methods for clinical utility;Seminars in Cancer Biology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3